ELBLANDKLINIKUM Riesa

Riesa 1589

0 studies enrolling now · 2 studies all time

What they study most

Paroxysmal Nocturnal Hemoglobinuria, Receptors, Fibroblast Growth Factor, Urothelial Cancer

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors — Running, not enrolling
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed